Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Variants of uncertain clinical significance in hereditary breast and ovarian cancer genes: best practices in functional analysis for clinical annotation.

Journal of medical genetics - 1 Aug 2020

Monteiro Alvaro N, Bouwman Peter, Kousholt Arne N, Eccles Diana M, Millot Gael A, Masson Jean-Yves, Schmidt Marjanka K, Sharan Shyam K, Scully Ralph, Wiesmüller Lisa, Couch Fergus, Vreeswijk Maaike P G

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Repair Mechanisms

Share to Genetic Predisposition to Disease

Share to Hereditary Breast and Ovarian Cancer Syndrome

Share to PARP inhibition in cancer therapy

Source

Open in PubMed Open full text

Identifiers

PMID: 32152249
DOI: 10.1136/jmedgenet-2019-106368
PMCID: PMC7390672

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Variants of uncertain clinical significance in hereditary breast and ovarian cancer genes: best practices in functional analysis for clinical annotation.PMID 32152249Read ↗

Variants of uncertain significance in breast cancer-related genes: real-world implications for a clinical conundrum. Part one: clinical genetics recommendations.Semantic proximity Read ↗

Variants of uncertain significance in the era of high-throughput genome sequencing: a lesson from breast and ovary cancers.Semantic proximity Read ↗

Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer.Semantic proximity Read ↗

Clinical validity assessment of genes frequently tested on hereditary breast and ovarian cancer susceptibility sequencing panelsSemantic proximity Read ↗

Germline Missense Variants in BRCA1: New Trends and Challenges for Clinical AnnotationSemantic proximity Read ↗

Changes in classification of genetic variants in BRCA1 and BRCA2.Semantic proximity Read ↗

Development of an Open Database of Genes Included in Hereditary Cancer Genetic Testing Panels Available From Major Sources in the US.Semantic proximity Read ↗

Complexities of Variant Classification in Clinical Hereditary Cancer Genetic Testing.Semantic proximity Read ↗

How does re-classification of variants of unknown significance (VUS) impact the management of patients at risk for hereditary breast cancer?Semantic proximity Read ↗

A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes.Semantic proximity Read ↗

BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning.Semantic proximity Read ↗

The Excess of Carriers in Rare Disorders Suggests a Nonpathogenic Effect for Most Variants of Uncertain Significance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.